We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+16.14%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$10.3B
AUM Growth
+$4.64B
Cap. Flow
+$4.08B
Cap. Flow %
39.44%
Top 10 Hldgs %
58.55%
Holding
192
New
69
Increased
39
Reduced
26
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 21.84%
2 Healthcare 13%
3 Industrials 5.98%
4 Communication Services 4.91%
5 Financials 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUVA
101
DELISTED
NuVasive, Inc.
NUVA
$2.27M 0.02%
+55,000
New +$2.35M
MBLY icon
102
Mobileye
MBLY
$2.2B
$2.16M 0.02%
50,000
+25,000
+100% +$979K
WMB icon
103
Williams Companies
WMB
$86.1B
$2.09M 0.02%
70,000
BAC icon
104
Bank of America
BAC
$442B
$1.86M 0.02%
65,000
+25,000
+63% +$825K
CRBG icon
105
Corebridge Financial
CRBG
$15B
$1.6M 0.02%
100,000
-25,000
-20% -$490K
SYF icon
106
Synchrony
SYF
$25.6B
$1.6M 0.02%
55,000
STHO icon
107
Star Holdings Shares of Beneficial Interest
STHO
$116M
$1.58M 0.02%
+91,031
New +$1.77M
NXPI icon
108
NXP Semiconductors
NXPI
$60.4B
$1.49M 0.01%
8,000
-1,500
-16% -$267K
NXPI icon
109
PUT
NXP Semiconductors
NXPI
$60.4B
$1.49M 0.01%
8,000
+5,000
+167% +$891K
RNLX
110
DELISTED
Renalytix plc American Depositary Shares
RNLX
$1.21M 0.01%
500,000
-100,000
-17% -$277K
TENB icon
111
Tenable Holdings
TENB
$4.01B
$1.19M 0.01%
+25,000
New +$1.06M
STRO icon
112
Sutro Biopharma
STRO
$421M
$1.18M 0.01%
25,500
+3,000
+13% +$190K
FRC
113
DELISTED
First Republic Bank
FRC
$1.12M 0.01%
+80,000
New +$8.2M
ADP icon
114
PUT
Automatic Data Processing
ADP
$108B
$1.11M 0.01%
+5,000
New +$1.13M
ALIT icon
115
PUT
Alight
ALIT
$407M
$1.11M 0.01%
+6,000
New +$1.1M
MLYS icon
116
Mineralys Therapeutics
MLYS
$2.41B
$1.1M 0.01%
+70,000
New +$1.18M
ETNB
117
DELISTED
89bio
ETNB
$1.07M 0.01%
+70,000
New +$913K
PLRX icon
118
Pliant Therapeutics
PLRX
$65M
$1.06M 0.01%
+40,000
New +$1.14M
IWM icon
119
iShares Russell 2000 ETF
IWM
$81.9B
$892K 0.01%
5,000
AMLX icon
120
Amylyx Pharmaceuticals
AMLX
$2.54B
$880K 0.01%
30,000
-5,000
-14% -$174K
PLTK icon
121
Playtika
PLTK
$1.12B
$788K 0.01%
70,000
-54,232
-44% -$544K
MDXH icon
122
MDxHealth
MDXH
$23.7M
$740K 0.01%
+228,300
New +$1.04M
FNA
123
DELISTED
Paragon 28, Inc.
FNA
$597K 0.01%
+35,000
New +$624K
ETNB
124
PUT
DELISTED
89bio
ETNB
$533K 0.01%
+35,000
New +$456K
RCL icon
125
Royal Caribbean
RCL
$85.6B
$522K 0.01%
8,000
-147,200
-95% -$9.71M

Similar funds

Pentwater Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Pentwater Capital Management held 192 positions worth $10.3B, up 81% from $5.7B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Pentwater Capital Management deployed $4.08B of net new capital in Q1 2023, opening 69 new positions and adding to 39 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 1,755,000 shares worth $355M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $107M trimmed.

  • Pentwater Capital Management's largest Q1 2023 buy was Seagen Inc. Common Stock: 1,755,000 shares worth $355M.
  • Pentwater Capital Management added most to Activision Blizzard in Q1 2023, an estimated $539M increase.
  • Pentwater Capital Management's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $107M.
  • Pentwater Capital Management fully exited STORE Capital Corporation in Q1 2023, selling an estimated $208M.
  • Pentwater Capital Management's ten largest holdings make up 59% of its $10.3B portfolio in Q1 2023.
  • Pentwater Capital Management opened 69 new positions and closed 48 in Q1 2023.
  • Pentwater Capital Management's portfolio value rose 81% quarter-over-quarter to $10.3B.

Based on Pentwater Capital Management's 13F filing for Q1 2023, filed 15 May 2023.